Field and Caspary (Lancet, 1970 (Lancet, , ii, 1337 Br. med. J., 1971, ii, 613) reported that peripheral lymphocytes from patients with malignant disease were sensitized to a basic protein (EF) derived from human brain. Sensitized lymphocytes in contact with EF produce a substance (macrophage slowing factor, MSF) capable of reducing the electrophoretic mobility of guinea-pig macrophages. The slowing of macrophages was shown to be related to the host malignant condition and a nonspecific test, the macrophage electrophoretic mobility (MEM) test for cancer was proposed. This was confirmed by Pritchard et al. (Lancet, 1972, ii, 627) . The MEM test in its original form was technically difficult to operate for two main reasons: (a) the equipment available to measure the electrophoretic mobility of macrophages was prone to many technical faults and (b) the selection of slowed macrophages within the macrophage population required considerable training. In order that the MEM test could become more acceptable in general laboratory
